Literature DB >> 20580505

Role of PROPELLER diffusion-weighted imaging and apparent diffusion coefficient in the evaluation of pituitary adenomas.

Omar M Mahmoud1, Atsushi Tominaga, Vishwa Jeet Amatya, Megu Ohtaki, Kazuhiko Sugiyama, Tetsuhiko Sakoguchi, Yasuyuki Kinoshita, Yukio Takeshima, Nobukazu Abe, Yuji Akiyama, Ahmad I El-Ghoriany, Abdel Karim H Abd Alla, Mostafa A M El-Sharkawy, Kazunori Arita, Kaoru Kurisu, Fumiyuki Yamasaki.   

Abstract

OBJECTIVE: The relationship between tumor consistency and apparent diffusion coefficient (ADC) values is controversial. We evaluated the role of the ADC using an advanced diffusion-weighted imaging (DWI) technique. We employed periodically rotated overlapping parallel lines with enhanced reconstruction (PROPELLER) DWI acquired on a 3-T magnetic resonance imaging (MRI) scanner to assess the consistency of pituitary adenomas and examined the relationship between the ADC and the hormone secretion status of the tumors and their MIB-1 labeling index (MIB-1 LI).
MATERIALS AND METHODS: The study protocol was approved by our institutional review board. We retrospectively studied 24 operated patients with pituitary adenomas who had undergone PROPELLER DWI on a 3-T MRI scanner. Conventional MRI findings were expressed as the ratio of the signal intensity (SI) in the lesions to the SI of the normal white matter and the degree of contrast enhancement. Minimum-, mean-, and maximum ADC (ADCmin, ADCmean, ADCmax) values were calculated. The consistency of the tumors was determined by neurosurgeons. All surgical specimens were submitted for histological study to calculate the MIB-1 LI and the percent collagen content. Preoperative MRI-, intraoperative-, and histological findings were analyzed by a statistician.
RESULTS: Our study included 15 soft-, 5 fibrous-, and 4 hard tumors. Tumor consistency was strongly associated with the percent collagen content. However, neither the tumor consistency nor the percent collagen content was correlated with MRI findings or ADC values. The SI of growth hormone-producing adenomas on T2-WI was lower than of the other pituitary adenomas studied (p<0.01); no other significant difference was found in the ADC or on conventional MRI between pituitary adenomas with different secretory functions. The MIB-1 LI of pituitary adenomas was not correlated with their appearance on conventional MRI or their ADC values.
CONCLUSION: Using the PROPELLER DWI technique we confirmed that the ADC was not correlated with the consistency of pituitary adenomas. We also demonstrate that the ADC was not associated with the hormone-secreting status or the MIB-1 LI of pituitary adenomas.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20580505     DOI: 10.1016/j.ejrad.2010.05.023

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  27 in total

1.  Diffusivity of intraorbital lymphoma vs. inflammation: comparison of single shot turbo spin echo and multishot echo planar imaging techniques.

Authors:  Akio Hiwatashi; Osamu Togao; Koji Yamashita; Kazufumi Kikuchi; Ryotaro Kamei; Hiroshi Yoshikawa; Atsushi Takemura; Hiroshi Honda
Journal:  Eur Radiol       Date:  2017-08-04       Impact factor: 5.315

2.  Predictive value of PWI for blood supply and T1-spin echo MRI for consistency of pituitary adenoma.

Authors:  Zengyi Ma; Wenqiang He; Yao Zhao; Jie Yuan; Qilin Zhang; Yue Wu; Hong Chen; Zhenwei Yao; Shiqi Li; Yongfei Wang
Journal:  Neuroradiology       Date:  2015-09-16       Impact factor: 2.804

3.  Accuracy of diffusion-weighted imaging-magnetic resonance in differentiating functional from non-functional pituitary macro-adenoma and classification of tumor consistency.

Authors:  Morteza Sanei Taheri; Farnaz Kimia; Mersad Mehrnahad; Hamidreza Saligheh Rad; Hamidreza Haghighatkhah; Afshin Moradi; Anahita Fathi Kazerooni; Mohammadreza Alviri; Abdorrahim Absalan
Journal:  Neuroradiol J       Date:  2018-12-03

4.  Evaluation of diffusivity in the anterior lobe of the pituitary gland: 3D turbo field echo with diffusion-sensitized driven-equilibrium preparation.

Authors:  A Hiwatashi; T Yoshiura; O Togao; K Yamashita; K Kikuchi; K Kobayashi; M Ohga; S Sonoda; H Honda; M Obara
Journal:  AJNR Am J Neuroradiol       Date:  2013-07-18       Impact factor: 3.825

5.  Diffusion-weighted imaging of the pituitary gland.

Authors:  M E Mullins
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-20       Impact factor: 3.825

6.  Endoscopic endonasal transsellar approach for laterally extended pituitary adenomas: volumetric analysis of cavernous sinus invasion.

Authors:  Masaaki Taniguchi; Kohkichi Hosoda; Nobuyuki Akutsu; Yutaka Takahashi; Eiji Kohmura
Journal:  Pituitary       Date:  2015-08       Impact factor: 4.107

7.  Intensity of prolactinoma on T2-weighted magnetic resonance imaging: towards another gender difference.

Authors:  Julie Kreutz; Laurent Vroonen; Francoise Cattin; Patrick Petrossians; Albert Thiry; Liliya Rostomyan; Luaba Tshibanda; Albert Beckers; Jean-François Bonneville
Journal:  Neuroradiology       Date:  2015-04-07       Impact factor: 2.804

8.  Predictive role of dynamic contrast enhanced T1-weighted MR sequences in pre-surgical evaluation of macroadenomas consistency.

Authors:  Andrea Romano; Valeria Coppola; Mariangela Lombardi; Luigi Lavorato; Domenica Di Stefano; Emanuela Caroli; Maria Camilla Rossi Espagnet; Francesca Tavanti; Giuseppe Minniti; Giuseppe Trillò; Alessandro Bozzao
Journal:  Pituitary       Date:  2017-04       Impact factor: 4.107

9.  Apparent diffusion coefficient and pituitary macroadenomas: pre-operative assessment of tumor atypia.

Authors:  Benita Tamrazi; Melike Pekmezci; Mariam Aboian; Tarik Tihan; Christine M Glastonbury
Journal:  Pituitary       Date:  2017-04       Impact factor: 4.107

10.  Pituitary macroadenoma: Accuracy of apparent diffusion coefficient magnetic resonance imaging in grading tumor aggressiveness.

Authors:  Mariko Doai; Hisao Tonami; Munetaka Matoba; Osamu Tachibana; Hideaki Iizuka; Satoko Nakada; Sohuske Yamada
Journal:  Neuroradiol J       Date:  2019-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.